Rebalix
Logo SPDRSPDR · sheet of 10 September 2026
ETF sheet · official issuer and register data

State Street® SPDR® S&P® U.S. Dividend Aristocrats Screened UCITS ETF (Dist)

ZPD6 · IE00BYTH5R14 · USD · domicile Ireland
Equity · North America · Dividend · Sustainable / ESGSFDR art. 8
Index tracked: S&P High Yield Dividend Aristocrats Screened Index
TER
0.35%+ trans. 0.02%
Fund size
21 m EUR
Tracking difference
+0.10%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Distributingquarterly
Launch 2 Jun 2021 · costs from the KID as of 2 Sept 2026 · 105 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
Investment objective The objective of the Fund is to track the U.S. equity market performance of certain high dividend-yielding equity securities. The Fund seeks to track the performance of the S&P High Yield Dividend Aristocrats Screened Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These securities include high-yielding stock from the U.S. equity market that meet the eligibility criteria defined…

Performance since series start (in euro) — base 100

3 Jun 20218 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2022202320242025202615098142
High 150 (28 Jul 2026) · low 98 (21 Sept 2021) · last 142. Past performance is not indicative of future results.

Returns in euro

1 year+15.2%
3 years+21.9%
5 years+41.3%
10 yearsseries too young
Since series start+41.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.43%12.71%14.04%
Max drawdown−8.80%−16.89%−16.89%
Sharpe0.860.350.19
Sortino1.310.510.27
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ZPD6 · IE00BYTH5R141
RebalixZPD6 · IE00BYTH5R14 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+5.71%+5.57%+0.14%
2024+4.96%+4.88%+0.08%
2023+1.82%+1.74%+0.08%
2022−0.07%−0.16%+0.09%
2021+5.08%+5.04%+0.04%

Distributions · per share, in USD

Frequency: quarterly · last 12 months: 0.5595 USD (2.31% of NAV) · last ex-date 22 Jun 2026
YearPaymentsTotal (USD)Dividend yield
202620.301
202540.5281+2.53%
202440.4373+2.15%
202340.4165+2.04%
202240.3982+1.91%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 105 securities · top-10 weight = 25.1%
Top holdingsWeight
Robert Half Inc.3.7%
Verizon Communications Inc.3.5%
Best Buy Co. Inc.2.5%
Target Corporation2.4%
Amcor PLC2.4%
Franklin Templeton Inc.2.3%
Edison International2.2%
J.M. Smucker Company2.1%
Realty Income Corporation2.0%
Kimberly-Clark Corporation2.0%
Countries (% of fund)
United States100.0%
Sectors (% of fund)
Consumer Staples19.4%Industrials18.8%Utilities14.7%Materials11.6%Financials8.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
ZPD6 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ssga.com/library-content/kids?isin=IE00BYTH5R14&documentType=kid&c
Factsheet · www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-e
Prospectus · www.ssga.com/library-content/products/fund-docs/etfs/emea/1-IE-EN-FP-I
The live sheet, always up to date
rebalix.com/en/etf/IE00BYTH5R14
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · ZPD6 · IE00BYTH5R142